Sarepta Therapeutics Inc (SRPT)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	235,239	121,845	47,297	16,897	-535,977	-690,876	-907,677	-1,115,218	-703,488	-716,225	-506,631	-356,555	-418,780	-486,116	-634,471	-703,886	-554,128	-600,514	-530,341	-655,924
Total assets	US$ in thousands	3,963,170	3,599,930	3,424,260	3,224,380	3,264,580	3,109,710	3,125,890	3,059,790	3,128,370	3,156,150	2,996,850	3,056,150	3,147,970	2,662,220	2,759,070	2,765,230	2,984,720	2,780,660	2,883,040	2,947,390
ROA		5.94%	3.38%	1.38%	0.52%	-16.42%	-22.22%	-29.04%	-36.45%	-22.49%	-22.69%	-16.91%	-11.67%	-13.30%	-18.26%	-23.00%	-25.45%	-18.57%	-21.60%	-18.40%	-22.25%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $235,239K ÷ $3,963,170K
= 5.94%

Sarepta Therapeutics Inc's return on assets (ROA) demonstrates a fluctuating trend over the analyzed period. The ROA was predominantly negative from March 2020 to June 2024, indicating that the company was generating less profit relative to its total assets. However, there was a significant improvement in performance starting from the fiscal year-end of December 2024, where the ROA turned positive. This shift suggests that Sarepta Therapeutics Inc may have enhanced its efficiency in asset utilization and profitability, resulting in a stronger financial position. The positive ROA from December 2024 onwards indicates that the company is generating more profit for each dollar of assets, potentially reflecting better management decisions or operational performance.